Advancement of platelet-inspired nanomedicine

References

• Modery-Pawlowski CL, Tian LL, Pan V, McCrae KR, Mitragotri S, Sen Gupta A. Approaches to synthetic platelet analogs. Biomaterials. 2013;34:526–541. doi:10.1016/j.biomaterials.2012.09.074.
   PubMed Web of Science ®Google Scholar
• Hu Q, Sun W, Qian C, Wang C, Bomba HN, Gu Z. Anticancer platelet-mimicking nanovehicles. Adv Mater. 2015;27(44):7043–7050. doi:10.1002/adma.201503323.
   PubMed Web of Science ®Google Scholar
• Pawlowski CL, Li W, Sun M, Ravichandran K, Hickman D, Kos C, Kaur G, Sen Gupta A. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis. Biomaterials. 2017;128:94–108. doi:10.1016/j.biomaterials.2017.03.012.
   PubMed Web of Science ®Google Scholar
• Annen K, Olson JE. Optimizing platelet transfusions. Curr Opin Hematol. 2015;22(6):559–564. doi:10.1097/MOH.0000000000000188.
   PubMed Web of Science ®Google Scholar
• Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60:S3–S11. doi:10.1097/01.ta.0000199961.02677.19.
   PubMed Web of Science ®Google Scholar
• Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the transfusion of plasma and platelets. Blood Transfus. 2009;7:132–150.
   PubMed Web of Science ®Google Scholar
• Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The retrovirus epidemiology donor study. N Engl J Med. 1996;334:1685–1690. doi:10.1056/NEJM199606273342601.
   PubMed Web of Science ®Google Scholar
• Brown AC, Stabenfeldt SE, Ahn B, Hannan RT, Dhada KS, Herman ES, Stefanelli V, Guzzetta N, Alexeev A, Lam WA, Lyon LA, Barker TH. Ultrasoft microgels displaying emergent platelet-like behaviours. Nat Mater. 2014;13:1108–1114. doi:10.1038/nmat4066.
   PubMed Web of Science ®Google Scholar
• Spotnitz WD. Fibrin sealant: the only approved hemostat, sealant, and adhesive – a laboratory and clinical perspective. ISRN Surg. 2014;2014:203943. doi:10.1155/2014/203943.
   PubMedGoogle Scholar
• Yeon JH, Chan KYT, Wong T-C, Chan K, Sutherland MR, Ismagilov RF, Pruzdial ELG, Kastrup CJ. A biochemical network can control formation of a synthetic material by sensing numerous specific stimuli. Sci Rep. 2015;5:10274. doi:10.1038/srep10274.
   PubMed Web of Science ®Google Scholar
• Chan LW, Wang X, Wei H, Pozzo LD, White NJ, Pun SH. A synthetic fibrin-crosslinking polymer for modulating clot properties and inducing hemostasis. Sci Transl Med. 2015 4;7(277):277ra29. doi:10.1126/scitranslmed.3010383.
   PubMed Web of Science ®Google Scholar
• Hsu BB, Conway W, Tschabrunn CM, Mehta M, Perez-Cuevas MB, Zhang S, Hammond PT. Clotting mimicry from robust hemostatic bandages based on self-assembling peptides. ACS Nano. 2015;9(9):9394–9406. doi:10.1021/acsnano.5b02374.
   PubMed Web of Science ®Google Scholar
• Avery RK, Albadawi H, Akbari M, Zhang YS, Duggan MJ, Sahani DV, Olsen BD, Khademhosseini A, Oklu R. An injectable shear-thinning biomaterial for endovascular embolization. Sci Transl Med. 2016 16;8(365):365ra156. doi:10.1126/scitranslmed.aah5533.
   PubMed Web of Science ®Google Scholar
• Rybak ME, Renzulli LA. A liposome based platelet substitute, the plateletsome, with hemostatic efficacy. Biomater Artif Cells Immobilization Biotechnol. 1993;21(2):101–118. doi:10.3109/10731199309117350.
   PubMed Web of Science ®Google Scholar
• Ravikumar M, Modery CL, Wong TL, Dzuricky M, Sen Gupta A. Mimicking adhesive functionalities of blood platelets using ligand-decorated liposomes. Bioconjug Chem. 2012 20;23(6):1266–1275. doi:10.1021/bc300086d.
   PubMed Web of Science ®Google Scholar
• Haji-Valizadeh H, Modery-Pawlowski CL, Sen Gupta A. A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets. Nanoscale. 2014 7;6(9):4765–4773. doi:10.1039/C3NR06400J.
   PubMed Web of Science ®Google Scholar
• Verhoef C, Singla N, Moneta G, Muir W, Rijken A, Lockstadt H, De Wilt JH, O-Yurvati A, Zuckerman LA, Frohna P, Porte RJ. Fibrocaps for surgical hemostasis: two randomized, controlled phase II trials. J Surg Res. 2015;194(2):679–687. doi:10.1016/j.jss.2014.12.011.
   PubMed Web of Science ®Google Scholar
• Okamura Y, Fujie T, Nogawa M, Maruyama H, Handa M, Ikeda Y, Takeoka S. Haemostatic effects of polymerized albumin particles carrying fibrinogen γ-chain dodecapeptide as platelet substitutes in severely thrombocytopenic rabbits. Transfus Med. 2008;18(3):158–166. doi:10.1111/j.1365-3148.2008.00860.x.
   PubMed Web of Science ®Google Scholar
• Okamura Y, Takeoka S, Eto K, Maekawa I, Fujie T, Maruyama H, Ikeda Y, Handa M. Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute. J Thromb Haemost. 2009;7(3):470–477. doi:10.1111/jth.2009.7.issue-3.
   PubMed Web of Science ®Google Scholar
• Ravikumar M, Modery CL, Wong TL, Sen GA. Peptide-decorated liposomes promote arrest and aggregation of activated platelets under flow on vascular injury relevant protein surfaces in vitro. Biomacromolecules. 2012 14;13(5):1495–1502. doi:10.1021/bm300192t.
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Modery-Pawlowski CL, Menegatti S, Kumar S, Vogus DR, Tian LL, Chen M, Squires TM, Sen Gupta A, Mitragotri S. Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries. ACS Nano. 2014 25;8(11):11243–11253. doi:10.1021/nn503732m.
   PubMed Web of Science ®Google Scholar
• Kanikarla-Marie P, Lam M, Menter DG, Kopetz S. Platelets, circulating tumor cells, and the circulome. Cancer Metastasis Rev. 2017:30. Epub ahead of print. doi:10.1007/s10555-017-9681-1.
   Web of Science ®Google Scholar
• Yang J, Wang SJ, Liu P, Dai L, Chen BA, Luan JF, Zhou JY. Platelet-inspired medicine for tumor therapy. Oncotarget. 2017;8(70):115748–115753. doi:10.18632/oncotarget.22853.
   PubMedGoogle Scholar
• Dai L, Gu N, Chen BA, Marriott G. Human platelets repurposed as vehicles for in vivo imaging of myeloma xenotransplants. Oncotarget. 2016 19;7(16):21076–21090. doi:10.18632/oncotarget.8517.
   PubMedGoogle Scholar
• Modery-Pawlowski CL, Master AM, Pan V, Howard GP, Sen Gupta A. A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms. Biomacromolecules. 2013 11;14(3):910–919. doi:10.1021/bm301996p.
   PubMed Web of Science ®Google Scholar
• Xu P, Zuo H, Chen B, Wang R, Ahmed A, Hu Y, Ouyang J. Doxorubicin-loaded platelets as a smart drug delivery system: an improved therapy for lymphoma. Sci Rep. 2017 15;7:42632. doi:10.1038/srep42632.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Alam MA, Shaw J, Dasgupta AK. Drug delivery using platelet cancer cell interaction. Pharm Res. 2013;30(11):2785–2794. doi:10.1007/s11095-013-1097-1.
   PubMed Web of Science ®Google Scholar
• Rao L, Bu LL, Ma L, Wang W, Liu H, Wan D, Liu JF, Li A, Guo SS, Zhang L, Zhang WF, Zhao XZ, Sun ZJ, Liu W. Platelet-facilitated photothermal therapy of head and neck squamous cell carcinoma. Angew Chem Int Ed Engl. 2017 Nov 29. doi:10.1002/anie.201709457.
   Web of Science ®Google Scholar
• Li J, Ai Y, Wang L, Bu P, Sharkey CC, Wu Q, Wun B, Roy S, Shen X, King MR. Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles. Biomaterials. 2016;76:52–65. doi:10.1016/j.biomaterials.2015.10.046.
   PubMed Web of Science ®Google Scholar
• Hyslop SR, Josefsson EC. Undercover agents: targeting tumours with modified platelets. Trends Cancer. 2017;3(3):235–246. doi:10.1016/j.trecan.2017.01.006.
   PubMed Web of Science ®Google Scholar
• Nandi S, Brown AC. Platelet-mimetic strategies for modulating the wound environment and inflammatory responses. Exp Biol Med (Maywood). 2016;241(10):1138–1148. doi:10.1177/1535370216647126.
   PubMed Web of Science ®Google Scholar
• Lippi G, Mattiuzzi C, Favaloro EJ. Novel and emerging therapies: thrombustargeted fibrinolysis. Semin Thromb Hemost. 2013;39(1):48–58.
   PubMed Web of Science ®Google Scholar
• Greineder CF, Howard MD, Carnemolla R, Cines DB, Muzykantov VR. Advanced drug delivery systems for antithrombotic agents. Blood. 2013 29;122(9):1565–1575. doi:10.1182/blood-2013-03-453498.
   PubMed Web of Science ®Google Scholar
• Absar S, Gupta N, Nahar K, Ahsan F. Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy. J Thromb Haemost. 2015;13(9):1545–1556. doi:10.1111/jth.13033.
   PubMed Web of Science ®Google Scholar
• Frakokhzad OC. Nanotechnology: platelet mimicry. Nature. 2015 1;526(7571):47–48. doi:10.1038/nature15218.
   PubMed Web of Science ®Google Scholar
• Hu CM, Fang RH, Wang KC, Luk BT, Thamphiwatana S, Dehaini D, Nguyen P, Angsantikul P, Wen CH, Kroll AV, Carpenter C, Ramesh M, Qu V, Patel SH, Zhu J, Shi W, Hofman FM, Chen TC, Gao W, Zhang K, Chien S, Zhang L. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015 1;526(7571):118–121. doi:10.1038/nature15373.
   PubMed Web of Science ®Google Scholar